z-logo
open-access-imgOpen Access
intranasal GDNF gene therapy approach for treating Parkinson's disease
Author(s) -
Aly
Publication year - 2017
Language(s) - Uncategorized
Resource type - Dissertations/theses
DOI - 10.17760/d20260243
Subject(s) - glial cell line derived neurotrophic factor , neuroprotection , neurotrophic factors , dopaminergic , dopamine , medicine , genetic enhancement , nasal administration , parkinson's disease , gene delivery , neuroscience , pharmacology , disease , biology , gene , biochemistry , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom